Monitoring and Population HealthPopulation Medicines Surveillance

From practice-wide cohorts to named patients.

Across the practice, high-risk medicines carry monitoring and review obligations; Reedley groups patients by what is due or outstanding and opens each as owned work; clinicians decide.

Illustrative demonstration · intended workflow
  • Cohorts for high-risk medicines and shared-care monitoring.
  • Patients due for review and recalls outstanding, in a prioritised queue.
  • Every cohort entry opens into the individual patient’s workflow.

Interactive demonstration

Synthetic practice data · pause, step and replay at any point

Population medicines surveillance

Synthetic data

Synthetic practice data · small, made-up counts

Step 1 of 6 · A synthetic practice list

  1. A synthetic practice list
  2. Cohorts from draft rules
  3. Each rule and its sign-off
  4. Prioritised work queue
  5. Open one cohort
  6. One patient’s workflow

Synthetic Practice

as at 31 Oct 2026 09:00

Every cohort comes from the practice’s own draft rule table: draft · unsigned · no named clinical owner yet.

Methotrexate · blood monitoring7 patients3 in the work queue“FBC, LFT and U&E every 12 weeks while on a stable dose of methotrexate.”Practice monitoring rule · draft · unsignedLithium · lithium level3 patients1 in the work queue“Lithium level every 6 months after the first year (draft; 3-monthly for the groups a clinician applies).”Practice monitoring rule · draft · unsignedDOACs · renal function older than the draft interval31 patients4 in the work queue“Renal function (serum creatinine for creatinine clearance), FBC and LFTs at least every 12 months while on a DOAC; more often for people over 75 or frail, or with creatinine clearance below 60 mL/min (draft, after SPS DOAC monitoring, updated 22 Oct 2026). The interval for each patient is set by a clinician.”Practice monitoring rule · draft · unsignedShared-care agreements · due for review9 agreements2 in the work queue“Shared-care agreement listed for review 30 days before its review date.”Practice monitoring rule · draft · unsigned · Illustrative: shared care is not builtStructured medication reviews due46 patients11 in the work queue“Structured medication review offered at least every 12 months to patients with 10 or more repeat medicines.”Practice monitoring rule · draft · unsignedRecalls outstanding9 recalls4 in the work queue“A timed review is outstanding from the start of its window until an attendance or a review is recorded.”Practice monitoring rule · draft · unsignedRecord patterns for a clinician’s review1 patient1 in the work queue“Methotrexate on repeat with no folic acid on repeat: listed for a clinician’s review.”Practice monitoring rule · draft · unsignedPrioritised work queue · all cohorts26 items need work15 past due · 10 due soon · 1 with no due dateOrdered by a stated rule, not a score: past due first, oldest due date first; then due soonest; items with no due date last.

Select a cohort to see its items and where they sit in the queue.

How this view is built

Draft rules first run across the synthetic practice list on 26 Oct 2026, so several items were already past due when found.

  1. Synthetic practice listas at 31 Oct 2026 09:00
  2. Draft rule table7 rules · draft · unsigned
  3. Cohorts7 cohorts counted
  4. Work queue26 items need work
  5. One patient’s workflowOwned, evidenced work

The 7 draft rules

  • Methotrexate · blood monitoring“FBC, LFT and U&E every 12 weeks while on a stable dose of methotrexate.”Practice monitoring rule · draft · unsigned
  • Lithium · lithium level“Lithium level every 6 months after the first year (draft; 3-monthly for the groups a clinician applies).”Practice monitoring rule · draft · unsigned
  • DOACs · renal function older than the draft interval“Renal function (serum creatinine for creatinine clearance), FBC and LFTs at least every 12 months while on a DOAC; more often for people over 75 or frail, or with creatinine clearance below 60 mL/min (draft, after SPS DOAC monitoring, updated 22 Oct 2026). The interval for each patient is set by a clinician.”Practice monitoring rule · draft · unsigned
  • Shared-care agreements · due for review“Shared-care agreement listed for review 30 days before its review date.”Practice monitoring rule · draft · unsigned · Illustrative: shared care is not built
  • Structured medication reviews due“Structured medication review offered at least every 12 months to patients with 10 or more repeat medicines.”Practice monitoring rule · draft · unsigned
  • Recalls outstanding“A timed review is outstanding from the start of its window until an attendance or a review is recorded.”Practice monitoring rule · draft · unsigned
  • Record patterns for a clinician’s review“Methotrexate on repeat with no folic acid on repeat: listed for a clinician’s review.”Practice monitoring rule · draft · unsigned

Items needing work, by cohort · 26 in all

  • Methotrexate · blood monitoring3 items
  • Lithium · lithium level1 item
  • DOACs · renal function older than the draft interval4 items
  • Shared-care agreements · due for review2 items
  • Structured medication reviews due11 items
  • Recalls outstanding4 items
  • Record patterns for a clinician’s review1 item
Show as a table
Items needing work by cohort
CohortItems needing work
Methotrexate · blood monitoring3
Lithium · lithium level1
DOACs · renal function older than the draft interval4
Shared-care agreements · due for review2
Structured medication reviews due11
Recalls outstanding4
Record patterns for a clinician’s review1
Total26

Prioritised work queue · 26 items

Ordered by a stated rule, not a score: past due first, oldest due date first; then due soonest; items with no due date last.

Due dates follow the draft rules.

  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not readOpen workflow for Ronald GIBBS →
  2. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
  3. 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
  4. 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
  5. 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
  6. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
  7. 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
  8. 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review

Showing 8 of 26 items needing work. Further down: 7 more past due · 10 due soon · 1 with no due date.

Methotrexate · blood monitoring

7 patients · 3 in the work queue

Rule

“FBC, LFT and U&E every 12 weeks while on a stable dose of methotrexate.”

Practice monitoring rule · draft · unsigned

Sign-off: draft · unsigned · no named clinical owner yet

How the 7 patients divide

  • Monitoring within the 12-week interval4Counted, not queued
  • Due within 14 days2In the work queue
  • Past due1In the work queue

Where its items sit in the prioritised queue

Due dates follow the draft rules.

  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
  2. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
  3. 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
  4. 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
  5. 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
  6. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksThis cohortDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
  7. 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
  8. 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
  1. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed

1 of its 3 items is among the first 8 of 26. Further down the queue: 2 due soon.

Lithium · lithium level

3 patients · 1 in the work queue

Rule

“Lithium level every 6 months after the first year (draft; 3-monthly for the groups a clinician applies).”

Practice monitoring rule · draft · unsigned

Sign-off: draft · unsigned · no named clinical owner yet

How the 3 patients divide

  • Level within the draft interval2Counted, not queued
  • Past due1In the work queue

Where its items sit in the prioritised queue

Due dates follow the draft rules.

  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
  2. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)This cohortDue 4 Sep 2026Past dueAssignedadmin team
  3. 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
  4. 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
  5. 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
  6. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
  7. 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
  8. 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
  1. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team

Its 1 item is among the first 8 of 26.

DOACs · renal function older than the draft interval

31 patients · 4 in the work queue

Rule

“Renal function (serum creatinine for creatinine clearance), FBC and LFTs at least every 12 months while on a DOAC; more often for people over 75 or frail, or with creatinine clearance below 60 mL/min (draft, after SPS DOAC monitoring, updated 22 Oct 2026). The interval for each patient is set by a clinician.”

Practice monitoring rule · draft · unsigned

Sign-off: draft · unsigned · no named clinical owner yet

How the 31 patients divide

  • U&E within 12 months27Counted, not queued
  • U&E older than 12 months4In the work queue

Where its items sit in the prioritised queue

Due dates follow the draft rules.

  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanThis cohortDue 3 Sep 2026Past dueActionedinvitation sent, not readOpen workflow for Ronald GIBBS →
  2. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
  3. 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
  4. 4Peter LOMAXNo U&E in the last 12 months while on apixabanThis cohortDue 20 Sep 2026Past dueAssignedadmin team
  5. 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
  6. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
  7. 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
  8. 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not readOpen workflow for Ronald GIBBS →
  2. 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team

2 of its 4 items are among the first 8 of 26. Further down the queue: 2 more past due.

Shared-care agreements · due for review

9 agreements · 2 in the work queue

Rule

“Shared-care agreement listed for review 30 days before its review date.”

Practice monitoring rule · draft · unsigned · Illustrative: shared care is not built

Sign-off: draft · unsigned · no named clinical owner yet

How the 9 agreements divide

  • Review date within 30 days2In the work queue
  • Review date later7Counted, not queued

Where its items sit in the prioritised queue

Due dates follow the draft rules.

  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
  2. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
  3. 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
  4. 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
  5. 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
  6. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
  7. 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
  8. 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review

None of its 2 items are among the first 8 of 26: past-due items come first. Further down the queue: 2 due soon.

Structured medication reviews due

46 patients · 11 in the work queue

Rule

“Structured medication review offered at least every 12 months to patients with 10 or more repeat medicines.”

Practice monitoring rule · draft · unsigned

Sign-off: draft · unsigned · no named clinical owner yet

How the 46 patients divide

  • Review recorded in the last 12 months35Counted, not queued
  • Due within 30 days6In the work queue
  • Past due5In the work queue

Where its items sit in the prioritised queue

Due dates follow the draft rules.

  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
  2. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
  3. 3Margaret DUNNENo structured medication review in 12 monthsThis cohortDue 12 Sep 2026Past dueIdentifiedawaiting review
  4. 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
  5. 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
  6. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
  7. 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
  8. 8Raymond PIKENo structured medication review in 12 monthsThis cohortDue 18 Oct 2026Past dueIdentifiedawaiting review
  1. 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
  2. 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review

2 of its 11 items are among the first 8 of 26. Further down the queue: 3 more past due · 6 due soon.

Recalls outstanding

9 recalls · 4 in the work queue

Rule

“A timed review is outstanding from the start of its window until an attendance or a review is recorded.”

Practice monitoring rule · draft · unsigned

Sign-off: draft · unsigned · no named clinical owner yet

How the 9 recalls divide

  • Inside their window5Counted, not queued
  • Past their window, no attendance recorded4In the work queue

Inside-window recalls are counted but not queued: booked is not attended, and the window has not ended.

Where its items sit in the prioritised queue

Due dates follow the draft rules.

  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
  2. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
  3. 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
  4. 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
  5. 5Sandra KEMPHypertension review window ended, no attendance recordedThis cohortDue 30 Sep 2026Past dueActionedinvitation sent, not read
  6. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
  7. 7Graham WEBBAsthma review window ended, no attendance recordedThis cohortDue 15 Oct 2026Past dueIdentifiedawaiting review
  8. 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review
  1. 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
  2. 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review

2 of its 4 items are among the first 8 of 26. Further down the queue: 2 more past due.

Record patterns for a clinician’s review

1 patient · 1 in the work queue

Rule

“Methotrexate on repeat with no folic acid on repeat: listed for a clinician’s review.”

Practice monitoring rule · draft · unsigned

Sign-off: draft · unsigned · no named clinical owner yet

The patient counted

  • Methotrexate on repeat without folic acid on repeat1In the work queue

Listed for a clinician to look at. Reedley does not judge whether a prescription is appropriate.

Where its items sit in the prioritised queue

Due dates follow the draft rules.

  1. 1Ronald GIBBSNHS 999 000 0654No U&E in the last 12 months while on rivaroxabanDOACs · renal function older than the draft intervalDue 3 Sep 2026Past dueActionedinvitation sent, not read
  2. 2Alan PRIESTLEYLithium level older than the draft interval (3-monthly, as recorded by a clinician)Lithium · lithium levelDue 4 Sep 2026Past dueAssignedadmin team
  3. 3Margaret DUNNENo structured medication review in 12 monthsStructured medication reviews dueDue 12 Sep 2026Past dueIdentifiedawaiting review
  4. 4Peter LOMAXNo U&E in the last 12 months while on apixabanDOACs · renal function older than the draft intervalDue 20 Sep 2026Past dueAssignedadmin team
  5. 5Sandra KEMPHypertension review window ended, no attendance recordedRecalls outstandingDue 30 Sep 2026Past dueActionedinvitation sent, not read
  6. 6Jean OAKLEYFBC, LFT and U&E older than 12 weeksMethotrexate · blood monitoringDue 14 Oct 2026Past dueActionedbooked 2 Nov · attendance not yet confirmed
  7. 7Graham WEBBAsthma review window ended, no attendance recordedRecalls outstandingDue 15 Oct 2026Past dueIdentifiedawaiting review
  8. 8Raymond PIKENo structured medication review in 12 monthsStructured medication reviews dueDue 18 Oct 2026Past dueIdentifiedawaiting review

Its 1 item is not among the first 8 of 26: past-due items come first. Further down the queue: 1 with no due date.

One patient’s workflow

From the cohort: DOACs · renal function older than the draft interval

Ronald GIBBSNHS 999 000 0654Born 17 Aug 1958 · 68 ySynthetic Practice

Work history

  1. IdentifiedReedley · draft rule“Identified: no U&E in the last 12 months while on rivaroxaban (draft rule)”Reedley work history · 26 Oct 2026 07:00
  2. ReviewedR. SHAH, clinical pharmacist“Reviewed by R. SHAH: evidence opened; item accepted.”Reedley work history · 26 Oct 2026 10:05
  3. AssignedR. SHAH“Assigned: admin team · due 14 Nov.”Reedley work history · 26 Oct 2026 10:06
  4. ActionedAdmin team · reported, not proven“Actioned: invitation sent by text (delivered, not read).”Reedley work history · 27 Oct 2026 09:30
  5. VerifiedNot reachedVerified only when a U&E result is received in the record; open until a clinician’s review of it is recorded.

On the record

Synthetic record

The passages cited above

Current medication

Rivaroxaban 20mg tablets · 20 mg once daily with food

U&E result

U&E: Na 138 mmol/L, K 4.4 mmol/L, creatinine 101 µmol/L, eGFR 63 mL/min/1.73m² · no laboratory flag

Actioned Actioned · awaiting evidence · sent is not read

See this item in My Day on 12 Nov →

Synthetic practice data. Population views are not in the development build; the rules are drafts with no named clinical owner.

Illustrative demonstration · intended workflow · Scripted reconstruction: the development build itself is not running on this page.

From what arrives to what you decide

  1. What entersMonitoring and review obligations across the practice
  2. What Reedley preparesPatients grouped by what is due or outstanding, each opening as owned work
  3. What the clinician decidesClinicians decide

What it does not do · what exists today

  • Reedley contacts no patient: each cohort entry becomes work for a named clinician.
  • Population runs would need bulk read access through a supplier route.
  • The rules behind every cohort are drafts awaiting a named clinical owner.
  • Not yet in Reedley’s intended-purpose register: shown to explore the workflow, not as committed product scope.

Every patient shown is synthetic. No integration with a clinical system is claimed, and no clinician has yet used Reedley in practice. Safety and governance

See it with your own work in mind.

Tell us your role and the workflows you care about, and we will walk you through them on synthetic data.